Indian Vancomycin Exporters: Complete Supplier Ranking with Market Share — 743 Manufacturers (2026) — TransData Nexus

Q: Who is the largest vancomycin buyer importing from India?

MYLAN INSTITUTIONAL INC 2898 (UNITED STATES) is the largest vancomycin importer from India with a 11.4% market share and import value of $10.5M.

Q: How many vancomycin buyers import from India?

There are 743 active vancomycin buyers importing from India, with a combined import market of $92.2M across 3,071 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top vancomycin buyers from India?

The top 5 vancomycin buyers — MYLAN INSTITUTIONAL INC 2898, MYLAN INSTITUTIONAL INC, EVERSANA, EUGIA US LLC,, DR.FRIEDRICH EBERTH ARZNEIMITTEL — together control 33.5% of total vancomycin import value from India.

Suresh Sormare

Vancomycin

India Pharmaceutical Trade Intelligence

$92.2M318 Suppliers140 CountriesHS 30042096

ExportsIndia → UNITED STATES54.8%India → GERMANY8.8%

ImportsCHINA → India$301.9K UNITED STATES → India$74.8K

#1 Supplier: MYLAN LABORATORIES #1 Buyer: MYLAN INSTITUTIONAL

Market Analysis: Top Importing Countries & Their Importers

1United States

United States emerges as the first largest importing country, achieving a total trade value of $50.6M through 381 shipments. This represents a market share of 54.8% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: United States has a diverse importer base, with their top importers including:

• MYLAN INSTITUTIONAL INC 2898 - $10.5M (20.7% of country's total business)

• MYLAN INSTITUTIONAL INC - $7.1M (14.0% of country's total business)

• EVERSANA - $6.6M (13.1% of country's total business)

• EUGIA US LLC, - $3.4M (6.8% of country's total business)

• MYLAN INSTITUTIONAL, INC - $3.0M (5.9% of country's total business)

• Rest of United States's importers - $20.0M (39.5% of country's total business)

Key Insight: United States demonstrates strong market positioning with an average shipment value of $132.7K, indicating premium pricing strategy compared to the market average of $30.0K.

United States is a key market for Vancomycin imports, representing 54.8% of total trade value.

Primary Market

Secondary Market

Buyer Segment Analysis

TransData Nexus Vancomycin buyer market intelligence

1Buyer Segment Analysis

The 743 buyers of Vancomycin from India can be categorized into several segments:

1. Distributors: Entities like EVERSANA (United States, $6.61M) and HANSE SERVICE INTERNATIONALE (Germany, $2.81M) fall into this category. These organizations purchase large quantities to supply hospitals, pharmacies, and healthcare providers. Their buying behavior is characterized by bulk orders and regular procurement cycles to maintain consistent supply chains.

2. Hospital Groups: While specific hospital groups are not listed among the top buyers, such entities typically procure Vancomycin directly to meet patient needs. Their orders are substantial and aligned with patient admission rates and treatment protocols.

3. Retail Chains: Retail pharmacy chains may also import Vancomycin to stock their outlets. Their purchasing patterns are influenced by consumer demand and prescription trends, leading to moderate-sized, periodic orders.

4. Government Procurement: Organizations like UNICEF and the Global Fund, along with national health departments, procure Vancomycin for public health initiatives. Their procurement is often through large-scale tenders, focusing on cost-effectiveness and broad distribution.

5. Re-exporters: Companies such as MYLAN AUSTRALIA (Australia, $2.79M) may act as re-exporters, importing Vancomycin from India to distribute in other markets. Their buying behavior includes large orders intended for redistribution.

6. Contract Manufacturers: Entities like EUGIA US LLC (United States, $3.43M) may import Vancomycin as raw material for further processing or formulation. Their procurement is based on production schedules and client demands.

Country-Specific Import Regulations

TransData Nexus Vancomycin buyer market intelligence

1Country-Specific Import Regulations

United States

1. Drug Regulatory Authority: U.S. Food and Drug Administration (FDA).

2. Import Registration Process: Importers must ensure that Vancomycin is FDA-approved. This involves submitting a New Drug Application (NDA) or Abbreviated New Drug Application (ANDA) for generic versions.

3. Estimated Timeline for Registration: The NDA process can take 6-10 months, while the ANDA process may take 8-10 months.

4. Import Tariff/Duty for HS 30042096: Pharmaceutical products under this HS code are generally duty-free in the U.S.

Germany

1. Drug Regulatory Authority: Federal Institute for Drugs and Medical Devices (BfArM).

2. Import Registration Process: Requires a Marketing Authorization Application (MAA) submission to BfArM, including comprehensive data on quality, safety, and efficacy.

3. Estimated Timeline for Registration: Approximately 7-12 months.

4. Import Tariff/Duty for HS 30042096: As an EU member, Germany applies a 0% duty rate on pharmaceutical products under this HS code.

Australia

1. Drug Regulatory Authority: Therapeutic Goods Administration (TGA).

2. Import Registration Process: Requires inclusion in the Australian Register of Therapeutic Goods (ARTG), involving submission of detailed dossiers.

3. Estimated Timeline for Registration: Typically 6-12 months.

4. Import Tariff/Duty for HS 30042096: Generally duty-free under Australia's tariff schedule.

Saudi Arabia

1. Drug Regulatory Authority: Saudi Food and Drug Authority (SFDA).

2. Import Registration Process: Requires product registration with SFDA, including submission of technical documents and samples.

Demand Drivers & Market Opportunity

TransData Nexus Vancomycin buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Vancomycin is primarily driven by the prevalence of severe bacterial infections, including methicillin-resistant *Staphylococcus aureus* (MRSA) and other Gram-positive infections. The inclusion of Vancomycin in the WHO Essential Medicines List underscores its critical role in treating such infections, facilitating its procurement through national healthcare systems and international health organizations. (who.int)

Government healthcare programs and the expansion of universal health coverage in various countries have increased access to essential antibiotics like Vancomycin. Tender-based purchasing mechanisms, often employed by public health agencies, ensure a steady demand for Vancomycin, as these entities prioritize cost-effective procurement of essential medicines to meet public health needs. (cdn.who.int)

TransData Nexus Research · Government and regulatory sourcesMar 2026

Common Questions — Vancomycin Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest vancomycin buyer importing from India?

Based on import volume and value, MYLAN INSTITUTIONAL INC 2898 (UNITED STATES) leads with $10.5M in imports and a 11.4% market share — the highest of any single vancomycin importer. MYLAN INSTITUTIONAL INC (UNITED STATES) and EVERSANA (UNITED STATES) are the next largest buyers.

QHow many companies buy vancomycin from India?

There are 743 active vancomycin buyers importing from India, with a combined market of $92.2M across 3,071 shipments to 140 countries. The top 5 buyers hold 33.5% of total import value, while the remaining 738 buyers handle the other 66.5%.

QWhich countries import the most vancomycin from India?

The top importing countries for vancomycin from India are United States (54.8%), Germany (8.8%), Australia (4.8%), Saudi Arabia (2.9%), Ethiopia (2.9%). These markets represent the largest demand centres for Indian pharmaceutical exports of vancomycin, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

QWhat is the average import order value for vancomycin from India?

The average import transaction value for vancomycin from India is , with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.

Buyer Segment Analysis

TransData Nexus Vancomycin buyer market intelligence

1Buyer Segment Analysis

The 743 buyers of Vancomycin from India can be categorized into several segments:

Country-Specific Import Regulations

TransData Nexus Vancomycin buyer market intelligence

1Country-Specific Import Regulations

United States

1. Drug Regulatory Authority: U.S. Food and Drug Administration (FDA).

3. Estimated Timeline for Registration: The NDA process can take 6-10 months, while the ANDA process may take 8-10 months.

4. Import Tariff/Duty for HS 30042096: Pharmaceutical products under this HS code are generally duty-free in the U.S.

Germany

1. Drug Regulatory Authority: Federal Institute for Drugs and Medical Devices (BfArM).

2. Import Registration Process: Requires a Marketing Authorization Application (MAA) submission to BfArM, including comprehensive data on quality, safety, and efficacy.

3. Estimated Timeline for Registration: Approximately 7-12 months.

4. Import Tariff/Duty for HS 30042096: As an EU member, Germany applies a 0% duty rate on pharmaceutical products under this HS code.

Australia

1. Drug Regulatory Authority: Therapeutic Goods Administration (TGA).

2. Import Registration Process: Requires inclusion in the Australian Register of Therapeutic Goods (ARTG), involving submission of detailed dossiers.

3. Estimated Timeline for Registration: Typically 6-12 months.

4. Import Tariff/Duty for HS 30042096: Generally duty-free under Australia's tariff schedule.

Saudi Arabia

1. Drug Regulatory Authority: Saudi Food and Drug Authority (SFDA).

2. Import Registration Process: Requires product registration with SFDA, including submission of technical documents and samples.

Demand Drivers & Market Opportunity

TransData Nexus Vancomycin buyer market intelligence

1Demand Drivers & Market Opportunity

TransData Nexus Research · Government and regulatory sourcesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Vancomycin

Vancomycin

Who Buys Vancomycin from India — 743 Importers Behind a $92.2M Market

Top Vancomycin Importers — Ranked by Import Value

Top Vancomycin Buyers & Importers

Related Analysis

Need Details?

Vancomycin — Export Intelligence Video

Market Analysis: Top Importing Countries & Importers

Which companies are buying Vancomycin — and from which countries?

Vancomycin — Buyer Countries to Key Importers

Market Analysis: Top Importing Countries & Their Importers

1United States

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Common Questions — Vancomycin Buyers & Importers

QWho is the largest vancomycin buyer importing from India?

QHow many companies buy vancomycin from India?

QWhich countries import the most vancomycin from India?

QWhat is the average import order value for vancomycin from India?

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

2Germany

3Australia

4Saudi Arabia

5Ethiopia

Analysis Methodology